<!DOCTYPE html>
<html lang="en">
	<head>
  		<meta charset="UTF-8">
  		<title>Bio2RDF - Drugbank</title>
		<link href="images/bio2rdf.png" rel="shortcut icon" />
		<link rel="stylesheet" type="text/css" href="css/style.css" media="screen" />
  		<script src="https://code.jquery.com/jquery-3.2.1.min.js"></script>
  		<script src="handlebars-v4.0.10.js"></script>
  		<!--<script src="https://cdnjs.cloudflare.com/ajax/libs/handlebars.js/4.0.10/handlebars.runtime.min.js"></script>-->
	
		<script type="application/ld+json">{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00087",
  "type" : "Drug",
  "administrationRoute" : "intravenous",
  "availableStrength" : [ {
    "id" : "http://bio2rdf.org/drugbank_resource:0e8f15e95b3dc9f0cb619404a7cd3939",
    "type" : "DrugStrength",
    "description" : "12 mg/1.2mL Injection, solution, concentrate form with intravenous route"
  }, {
    "id" : "http://bio2rdf.org/drugbank_resource:7d1fa8da4b3d71e38528197f4614759b",
    "type" : "DrugStrength",
    "description" : "12 mg Solution form with intravenous route"
  }, {
    "id" : "http://bio2rdf.org/drugbank_resource:b109960d084f038b36f8ebe5aefb1616",
    "type" : "DrugStrength",
    "description" : "30 mg/mL Injection form with intravenous route"
  }, {
    "id" : "http://bio2rdf.org/drugbank_resource:e2838256b2a0ac70b9d8c65f92a858c2",
    "type" : "DrugStrength",
    "description" : "30 mg Solution form with intravenous route"
  } ],
  "clinicalPharmacology" : "Campath is used to treat leukemia by exploiting antibody mediated lysis of CD52 presenting cells. The CD52 antigen is a cell surface protein found on essentially all B and T lymphocytes, a majority of monocytes, macrophages and most granulocytes. The CD52 antigen is not present on erythrocytes or hematopoetic stem cells. In leukemia there is an excess of B and T cells, so Campath permits selective reduction of lymphocyte populations.",
  "cost" : [ {
    "id" : "http://bio2rdf.org/drugbank_resource:8b785308649c5ce0ea4ea4de82ef6c89",
    "type" : "DrugCost",
    "costCurrency" : "USD",
    "costPerUnit" : "6179.240234375",
    "drugUnit" : "Campath 30 mg/ml Solution (1 Box Contains Three 1ml Vials)"
  }, {
    "id" : "http://bio2rdf.org/drugbank_resource:d7226a705948cd2ef76fd676fc47a4f6",
    "type" : "DrugCost",
    "costCurrency" : "USD",
    "costPerUnit" : "2042.1800537109375",
    "drugUnit" : "Campath 30 mg/ml vial"
  } ],
  "description" : "Humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein,CD52. The Campath-1H antibody is an IgG1 kappa with human variable framework and constant regions, and complementarity-determining regions from a murine (rat) monoclonal antibody (Campath-1G). Campath is produced in mammalian cell (Chinese hamster ovary) suspension culture in a medium containing neomycin.",
  "dosageForm" : [ "Solution", "Injection", "Injection, solution, concentrate" ],
  "schema:identifier" : "drugbank:DB00087",
  "interactingDrug" : [ "DDI between Alemtuzumab and Sipuleucel-T - Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.", "DDI between Trastuzumab and Alemtuzumab - May enhance the neutropenic effect of Immunosuppressants.", "DDI between Alemtuzumab and Clozapine - Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.", "DDI between Alemtuzumab and Roflumilast - May enhance the immunosuppressive effect of Immunosuppressants.", "DDI between Alemtuzumab and Pimecrolimus - May enhance the adverse/toxic effect of Immunosuppressants.", "DDI between Alemtuzumab and Belimumab - Monoclonal Antibodies may enhance the adverse/toxic effect of Belimumab.", "DDI between Alemtuzumab and Natalizumab - Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.", "DDI between Alemtuzumab and Denosumab - May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.", "DDI between Alemtuzumab and Leflunomide - Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.", "DDI between Alemtuzumab and Tofacitinib - Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib." ],
  "legalStatus" : [ "Approved", "Investigational" ],
  "mechanismOfAction" : "Campath binds to the CD52 antigen present on most B and T lymphocytes. This binding leads to antibody-dependent lysis of leukemic cells.",
  "name" : "Alemtuzumab",
  "sameAs" : [ "http://www.rxlist.com/cgi/generic/campath.htm", "http://www.drugs.com/cdi/alemtuzumab.html", "http://www.drugbank.ca/drugs/DB00087" ],
  "schema:url" : "http://bio2rdf.org/drugbank:DB00087"
}</script>
	</head>

	<body>
		<br/><br/>
		
		<div id="all">
	 		<div id="main" style="text-align: center;">
	 			<div style="height: 20%;">&nbsp;</div>
	 			<img alt="Drugbank" src="images/drugbank.png" />
	 			<div id="main" style="text-align: center;">
	 				<em>Bio2RDF Drugbank Data</em>
				</div>

				<br/><br/>

			</div>

			<div id="contents">
				<script type="text/javascript">

				var templateCode = "<table><tbody><tr><td class='dataframeKey'>Drug Name</td><td>{{name}}</td></tr><tr><td class='dataframeKey'>Description</td><td>{{description}}</td></tr><tr><td class='dataframeKey'>Identifier</td><td>{{schema:identifier}}</td></tr><tr><td class='dataframeKey'>Non-Proprietary Names</td><td><ul>{{#each nonProprietaryName}}<li>{{this}}</li>{{else}}{{nonProprietaryName}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Proprietary Name</td><td>{{proprietaryName}}</td></tr><tr><td class='dataframeKey'>Drug Classes</td><td><ul>{{#each drugClass}}<li>{{this}}</li>{{else}}{{drugClass}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Clinical Pharmacology</td><td>{{clinicalPharmacology}}</td></tr><tr><td class='dataframeKey'>Manufacturer</td><td>{{#with manufacturer}}{{name}}{{/with}}</td></tr><tr><td class='dataframeKey'>Mechanism of Action</td><td>{{mechanismOfAction}}</td></tr><tr><td class='dataframeKey'>Food Warning</td><td>{{foodWarning}}</td></tr><tr><td class='dataframeKey'>URL</td><td><a href='{{schema:url}}'>{{schema:url}}</a></td></tr><tr><td class='dataframeKey'>Costs</td><td>{{#if cost.length}}<ul>{{#each cost}}<li>{{#with this}}{{drugUnit}} - {{costPerUnit}}{{costCurrency}}{{/with}}</li>{{/each}}</ul>{{else}}{{#with cost}}{{drugUnit}} - {{costPerUnit}}{{costCurrency}}{{/with}}{{/if}}</td></tr><tr><td class='dataframeKey'>Available Strength</td><td>{{#if availableStrength.length}}<ul>{{#each availableStrength}}<li>{{this.description}}</li>{{/each}}</ul>{{else}}{{#with availableStrength}}{{description}}{{/with}}{{/if}}</td></tr><tr><td class='dataframeKey'>Dosage Forms</td><td><ul>{{#each dosageForm}}<li>{{this}}</li>{{else}}{{dosageForm}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Administration Route</td><td><ul>{{#each administrationRoute}}<li>{{this}}</li>{{else}}{{administrationRoute}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Interacting Drugs</td><td><ul>{{#each interactingDrug}}<li>{{this}}</li>{{else}}{{interactingDrug}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Legal Statuses</td><td><ul>{{#each legalStatus}}<li>{{this}}</li>{{else}}{{legalStatus}}{{/each}}</ul></td></tr><tr><td class='dataframeKey'>Same As</td><td><ul>{{#each sameAs}}<li><a href='{{this}}'>{{this}}</a></li>{{else}}<a href='{{sameAs}}'>{{sameAs}}</a>{{/each}}</ul></td></tr></tbody></table>";
				var template = Handlebars.compile(templateCode);

				$.getJSON("jsonld/DB00087.json", function(data) {
			    	document.getElementById("contents").innerHTML += template(data);
				});
		
				</script>
			</div>
		</div>
	</body>
</html>